| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9233112 | LUPIN LTD | Pharmaceutical compositions of cefixime |
Dec, 2028
(5 years from now) | |
Suprax is owned by Lupin Ltd.
Suprax contains Cefixime.
Suprax has a total of 1 drug patent out of which 0 drug patents have expired.
Suprax was authorised for market use on 20 February, 2013.
Suprax is available in for suspension;oral dosage forms.
Suprax can be used as methods for treating bacterial infections.
The generics of Suprax are possible to be released after 14 December, 2028.
Drugs and Companies using CEFIXIME ingredient
Market Authorisation Date: 20 February, 2013
Treatment: Methods for treating bacterial infections
Dosage: FOR SUSPENSION;ORAL
How can I launch a generic of SUPRAX before it's drug patent expiration?
More Information on Dosage
SUPRAX family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic